A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman, SM Chang… - Neuro …, 2010 - academic.oup.com
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …
被引用次数：340 相关文章

[引用][C] A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman, SM Chang… - Neuro-Oncology, 2009 - cir.nii.ac.jp
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive
glioblastoma multiforme postradiation therapy | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF] researchgate.net

[PDF][PDF] A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman, SM Chang… - Neuro …, 2010 - researchgate.net
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …
[PDF] psu.edu

[PDF][PDF] A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman, SM Chang… - Neuro-Oncology, 2010 - Citeseer
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman… - Neuro …, 2010 - scholars.northwestern.edu
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …
[PDF] academia.edu

[PDF][PDF] A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman, SM Chang… - Neuro …, 2010 - academia.edu
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman… - Neuro …, 2010 - mdanderson.elsevierpure.com
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.

JJ Raizer, LE Abrey, AB Lassman, SM Chang… - Neuro …, 2009 - europepmc.org
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …

A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman… - Neuro …, 2010 - pubmed.ncbi.nlm.nih.gov
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …
[HTML] nih.gov

[HTML][HTML] A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy

JJ Raizer, LE Abrey, AB Lassman, SM Chang… - Neuro …, 2010 - ncbi.nlm.nih.gov
Patients with (a) recurrent malignant glioma (MG): glioblastoma (GBM) or recurrent
anaplastic glioma (AG), and (b) nonprogressive (NP) GBM following radiation therapy (RT) …